Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.！
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Kx 01 Intermediate
Kx2-391 (Kx01) Is The First Peptide-Like Src Inhibitor To Enter Clinical Practice, Targeting The Binding Site Of Polypeptide Substrates Of Src. It Is 9-60 Nm For Many Cancer Cell Lines Gi50.
No data
